| Universal chimeric antigen receptors for multiplexed and logical control of T cell responses JH Cho, JJ Collins, WW Wong Cell 173 (6), 1426-1438. e11, 2018 | 553 | 2018 |
| Nanopatterned smart polymer surfaces for controlled attachment, killing, and release of bacteria Q Yu, J Cho, P Shivapooja, LK Ista, GP López ACS applied materials & interfaces 5 (19), 9295-9304, 2013 | 263 | 2013 |
| Engineering advanced logic and distributed computing in human CAR immune cells JH Cho, A Okuma, K Sofjan, S Lee, JJ Collins, WW Wong Nature communications 12 (1), 792, 2021 | 84 | 2021 |
| Coordinated regulation of acid resistance in Escherichia coli P Aquino, B Honda, S Jaini, A Lyubetskaya, K Hosur, JG Chiu, I Ekladious, ... BMC systems biology 11, 1-15, 2017 | 69 | 2017 |
| CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity J Joung, PC Kirchgatterer, A Singh, JH Cho, SP Nety, RC Larson, ... Nature Communications 13 (1), 1606, 2022 | 54 | 2022 |
| Engineering Axl specific CAR and SynNotch receptor for cancer therapy JH Cho, A Okuma, D Al-Rubaye, E Intisar, RP Junghans, WW Wong Scientific reports 8 (1), 3846, 2018 | 54 | 2018 |
| High-performance chemical-and light-inducible recombinases in mammalian cells and mice BH Weinberg, JH Cho, Y Agarwal, NTH Pham, LD Caraballo, M Walkosz, ... Nature communications 10 (1), 4845, 2019 | 51 | 2019 |
| Synthetic biology: immunotherapy by design J Brenner, JH Cho, NML Wong, WW Wong Annual review of biomedical engineering 20, 95-118, 2018 | 29 | 2018 |
| Sensing with modular receptors J Brenner, JH Cho, WW Wong Nature chemical biology 13 (2), 131-132, 2017 | 17 | 2017 |
| Synthetic biology approaches in cancer immunotherapy, genetic network engineering, and genome editing D Chakravarti, JH Cho, BH Weinberg, NM Wong, WW Wong Integrative biology 8 (4), 504-517, 2016 | 16 | 2016 |
| Methods and compositions relating to chimeric antigen receptors W Wong, JH Cho | 6 | 2017 |
| CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity. Nat. Commun. 13, 1606 J Joung, PC Kirchgatterer, A Singh, JH Cho, SP Nety, RC Larson, ... | 5 | 2022 |
| Synthetic Biology Meets CAR-T Cell Therapy JH CHO 한국생물공학회 학술대회, 90-90, 2023 | | 2023 |
| Methods and compositions relating to chimeric antigen receptors JH Cho US Patent App. 18/053,432, 2023 | | 2023 |
| Engineering Axl specific CAR and SynNotch receptor for cancer therapy (vol 8, 3846, 2018) JH Cho, A Okuma, D Al-Rubaye, E Intisar, RP Junghans, WW Wong SCIENTIFIC REPORTS 10 (1), 2020 | | 2020 |
| Author Correction: Engineering Axl specific CAR and SynNotch receptor for cancer therapy JH Cho, A Okuma, D Al-Rubaye, E Intisar, RP Junghans, WW Wong Scientific Reports 10, 2020 | | 2020 |
| METHOD AND COMPOSITIONS RELATED TO CHIMERIC ANTIGEN RECEPTORS W Wong, JH Cho | | 2019 |
| Synthetic biology approaches to improve cell-based cancer immunotherapy JH Cho | | 2019 |
